{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:46:38Z","timestamp":1793699198181,"version":"4.5.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10620-019-05786-1","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T04:16:38Z","timestamp":1566879398000},"page":"416-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients"],"prefix":"10.1007","volume":"65","author":[{"given":"Mehmet","family":"Sayiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"De Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Golabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Racila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-577X","authenticated-orcid":false,"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"5786_CR1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261\u20131273.","journal-title":"N Engl J Med"},{"key":"5786_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","volume":"52","author":"R Poupon","year":"2010","unstructured":"Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010;52:745\u2013758.","journal-title":"J Hepatol"},{"key":"5786_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","volume":"11","author":"A Lleo","year":"2017","unstructured":"Lleo A, Marzorati S, Anaya J-M, Gershwin ME. Primary biliary cholangitis: a comprehensive overview. Hepatol Int. 2017;11:485\u2013499.","journal-title":"Hepatol Int"},{"key":"5786_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30174","author":"M Sayiner","year":"2018","unstructured":"Sayiner M, Golabi P, Stepanova M, et al. Primary biliary cholangitis in medicare population: the impact on mortality and resource utilization. Hepatology. 2018. \nhttps:\/\/doi.org\/10.1002\/hep.30174\n\n.","journal-title":"Hepatology"},{"key":"5786_CR5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet. 2011;377:1600\u20131609.","journal-title":"Lancet"},{"key":"5786_CR6","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1111\/liv.12434","volume":"34","author":"K Boonstra","year":"2014","unstructured":"Boonstra K, Kunst AE, Stadhouders PH, et al. Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study. Liver Int. 2014;34:e31\u2013e38.","journal-title":"Liver Int"},{"key":"5786_CR7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","volume":"119","author":"WR Kim","year":"2000","unstructured":"Kim WR, Lindor KD, Locke GR 3rd, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000;119:1631\u20131636.","journal-title":"Gastroenterology"},{"key":"5786_CR8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hep.510230108","volume":"23","author":"GR Locke 3rd","year":"1996","unstructured":"Locke GR 3rd, Therneau TM, Ludwig J, Dickson ER, Lindor KD. Time course of histological progression in primary biliary cirrhosis. Hepatology. 1996;23:52\u201356.","journal-title":"Hepatology"},{"key":"5786_CR9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386:1565\u20131575.","journal-title":"Lancet"},{"key":"5786_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000282073","volume":"28","author":"C Selmi","year":"2010","unstructured":"Selmi C, Gershwin ME. The etiology mystery in primary biliary cirrhosis. Dig Dis. 2010;28:105\u2013115.","journal-title":"Dig Dis"},{"key":"5786_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0031-1276644","volume":"31","author":"GM Hirschfield","year":"2011","unstructured":"Hirschfield GM, Invernizzi P. Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis. 2011;31:147\u2013156.","journal-title":"Semin Liver Dis"},{"key":"5786_CR12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cld.2017.06.005","volume":"21","author":"BE Burman","year":"2017","unstructured":"Burman BE, Jhaveri MA, Kowdley KV. An update on the treatment and follow-up of patients with primary biliary cholangitis. Clin Liver Dis. 2017;21:709\u2013723.","journal-title":"Clin Liver Dis"},{"key":"5786_CR13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"5786_CR14","first-page":"66","volume":"1","author":"N Akamatsu","year":"2012","unstructured":"Akamatsu N, Sugawara Y. Primary biliary cirrhosis and liver transplantation. Intract. Rare Dis. Res. 2012;1:66\u201380.","journal-title":"Intract. Rare Dis. Res."},{"key":"5786_CR15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EMM Kuiper","year":"2009","unstructured":"Kuiper EMM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009;136:1281\u20131287.","journal-title":"Gastroenterology"},{"key":"5786_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/cld.311","volume":"3","author":"A Par\u00e9s","year":"2014","unstructured":"Par\u00e9s A. Treatment of primary biliary cirrhosis: Is there more to offer than ursodeoxycholic acid? Treatment of primary biliary cirrhosis and UDCA. Clin. Liver Dis.. 2014;3:29\u201333.","journal-title":"Clin. Liver Dis."},{"key":"5786_CR17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631\u2013643.","journal-title":"N Engl J Med"},{"key":"5786_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2015.08.011","volume":"20","author":"V Khungar","year":"2016","unstructured":"Khungar V, Goldberg DS. Liver transplantation for cholestatic liver diseases in adults. Clin Liver Dis. 2016;20:191\u2013203.","journal-title":"Clin Liver Dis"},{"key":"5786_CR19","doi-asserted-by":"crossref","first-page":"e11518","DOI":"10.1097\/MD.0000000000011518","volume":"97","author":"P Golabi","year":"2018","unstructured":"Golabi P, Bush H, Stepanova M, et al. Liver transplantation (LT) for cryptogenic cirrhosis (CC) and nonalcoholic steatohepatitis (NASH) cirrhosis: data from the scientific registry of transplant recipients (SRTR): 1994 to 2016. Medicine. 2018;97:e11518.","journal-title":"Medicine"},{"key":"5786_CR20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid2203.151650","volume":"22","author":"RB Perumpail","year":"2016","unstructured":"Perumpail RB, Wong RJ, Liu A, et al. Trends in liver transplantation in hepatitis C virus-infected persons, United States. Emerg Infect Dis. 2016;22:565\u2013567.","journal-title":"Emerg Infect Dis"},{"key":"5786_CR21","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.jhep.2016.07.005","volume":"65","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Birerdinc A, Henry L. Hepatitis C infection: a multi-faceted systemic disease with clinical, patient reported and economic consequences. J Hepatol. 2016;65:S109\u2013S119.","journal-title":"J Hepatol"},{"key":"5786_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpgasthep0070","volume":"2","author":"RH Wiesner","year":"2005","unstructured":"Wiesner RH. Patient selection in an era of donor liver shortage: current US policy. Nat Clin Pract Gastroenterol Hepatol. 2005;2:24\u201330.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"5786_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464\u2013470.","journal-title":"Hepatology"},{"key":"5786_CR24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/tri.12877","volume":"30","author":"AK Singal","year":"2017","unstructured":"Singal AK, Fang X, Kaif M, et al. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation. Transpl Int. 2017;30:454\u2013462.","journal-title":"Transpl Int"},{"key":"5786_CR25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jceh.2013.08.004","volume":"3","author":"A Shukla","year":"2013","unstructured":"Shukla A, Vadeyar H, Rela M, Shah S. Liver transplantation: East versus West. J Clin Exp Hepatol. 2013;3:243\u2013253.","journal-title":"J Clin Exp Hepatol"},{"key":"5786_CR26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MOG.0b013e3283457d5d","volume":"27","author":"SA Alqahtani","year":"2011","unstructured":"Alqahtani SA, Larson AM. Adult liver transplantation in the USA. Curr Opin Gastroenterol. 2011;27:240\u2013247.","journal-title":"Curr Opin Gastroenterol"},{"key":"5786_CR27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2014.05.002","volume":"18","author":"EC Verna","year":"2014","unstructured":"Verna EC. Hepatitis viruses and liver transplantation: evolving trends in antiviral management. Clin Liver Dis. 2014;18:575\u2013601.","journal-title":"Clin Liver Dis"},{"key":"5786_CR28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","volume":"5","author":"J Lee","year":"2007","unstructured":"Lee J, Belanger A, Doucette JT, et al. Transplantation trends in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2007;5:1313\u20131315.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5786_CR29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1517\/14740338.2015.1073260","volume":"14","author":"JH Tabibian","year":"2015","unstructured":"Tabibian JH, Lindor KD. Primary biliary cirrhosis: safety and benefits of established and emerging therapies. Expert Opin Drug Saf. 2015;14:1435\u20131444.","journal-title":"Expert Opin Drug Saf"},{"key":"5786_CR30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jhep.2011.04.012","volume":"55","author":"U Beuers","year":"2011","unstructured":"Beuers U, Lindor KD. A major step towards effective treatment evaluation in primary biliary cirrhosis. J Hepatol. 2011;55:1178\u20131180.","journal-title":"J Hepatol"},{"key":"5786_CR31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00535-013-0782-5","volume":"49","author":"T Genda","year":"2014","unstructured":"Genda T, Ichida T, Sakisaka S, et al. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol. 2014;49:324\u2013331.","journal-title":"J Gastroenterol"},{"key":"5786_CR32","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.27704","volume":"61","author":"JK Heimbach","year":"2015","unstructured":"Heimbach JK, Hirose R, Stock PG, et al. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology. 2015;61:1643\u20131650.","journal-title":"Hepatology"},{"key":"5786_CR33","first-page":"194","volume":"31","author":"W Sch\u00f6ning","year":"2015","unstructured":"Sch\u00f6ning W, Schmeding M, Ulmer F, Andert A, Neumann U. Liver transplantation for patients with cholestatic liver diseases. Viszeralmedizin. 2015;31:194\u2013198.","journal-title":"Viszeralmedizin"},{"key":"5786_CR34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-230X-10-144","volume":"10","author":"EMM Kuiper","year":"2010","unstructured":"Kuiper EMM, Hansen BE, Metselaar HJ, et al. Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988\u20132008. BMC Gastroenterol. 2010;10:144.","journal-title":"BMC Gastroenterol"},{"key":"5786_CR35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.hpb.2018.03.013","volume":"20","author":"K Staufer","year":"2018","unstructured":"Staufer K, Kivaranovic D, Rasoul-Rockenschaub S, et al. Waitlist mortality and post-transplant survival in patients with cholestatic liver disease\u2014impact of changes in allocation policy. HPB. 2018;20:916\u2013924.","journal-title":"HPB"},{"key":"5786_CR36","doi-asserted-by":"crossref","first-page":"S-1097","DOI":"10.1016\/S0016-5085(18)33653-9","volume":"154","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Stepanova M, Golabi P, et al. Factors associated with progressive course of patients with primary biliary cholangitis in the United States: data from a large-real world database. Gastroenterology. 2018;154:S-1097.","journal-title":"Gastroenterology"},{"key":"5786_CR37","doi-asserted-by":"crossref","first-page":"5262560","DOI":"10.1155\/2017\/5262560","volume":"2017","author":"X Ding","year":"2017","unstructured":"Ding X, Xu Y, Wang Y, et al. Nonalcoholic fatty liver disease and associated metabolic risks of hypertension in type 2 diabetes: a cross-sectional community-based study. Int J Endocrinol. 2017;2017:5262560.","journal-title":"Int J Endocrinol"},{"key":"5786_CR38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","volume":"16","author":"GJ Webb","year":"2018","unstructured":"Webb GJ, Rana A, Hodson J, et al. Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists. Clin Gastroenterol Hepatol. 2018;16:278\u2013287.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5786_CR39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2741\/3966","volume":"17","author":"P Milkiewicz","year":"2012","unstructured":"Milkiewicz P, Wunsch E, Elias E. Liver transplantation in chronic cholestatic conditions. Front Biosci. 2012;17:959\u2013969.","journal-title":"Front Biosci"},{"issue":"8","key":"5786_CR40","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","volume":"16","author":"M Lu","year":"2018","unstructured":"Lu M, Zhou Y, Haller IV, et al. Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment. Clin Gastroenterol Hepatol.. 2018;16(8):1342\u20131350.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"5786_CR41","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","volume":"95","author":"AK Singal","year":"2013","unstructured":"Singal AK, Guturu P, Hmoud B, et al. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95:755\u2013760.","journal-title":"Transplantation"},{"key":"5786_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/lt.25321","volume":"1","author":"C Levy","year":"2018","unstructured":"Levy C. Primary biliary cholangitis guidance update: implications for liver transplantation. Liver Transpl. 2018;1:1. \nhttps:\/\/doi.org\/10.1002\/lt.25321\n\n.","journal-title":"Liver Transpl"},{"key":"5786_CR43","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","volume":"14","author":"R Kashyap","year":"2010","unstructured":"Kashyap R, Safadjou S, Chen R, et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases\u2013an analysis of the UNOS database. J Gastrointest Surg. 2010;14:1362\u20131369.","journal-title":"J Gastrointest Surg"},{"key":"5786_CR44","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/ajt.13171","volume":"15","author":"R Adam","year":"2015","unstructured":"Adam R, Karam V, Delvart V, et al. Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transpl. 2015;15:1267\u20131282.","journal-title":"Am J Transpl"},{"key":"5786_CR45","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","volume":"16","author":"H Egawa","year":"2016","unstructured":"Egawa H, Sakisaka S, Teramukai S, et al. Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study. Am J Transpl. 2016;16:1248\u20131257.","journal-title":"Am J Transpl"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05786-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:24:44Z","timestamp":1598397884000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05786-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5786"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05786-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"ZMY is a consultant to BMS, Gilead, AbbVie, Intercept, and GSK. All other authors of this manuscript have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}